While Retail Panics on Bitcoin, I’m Loading Up On These 2 Q3 Stocks
3 extracted signals · 3 resolved · 0 still active
KrownIndependent analyst profile- Source published
- 29 Jun 2026, 23:16 UTC
- Recorded by Tahlil Plus
- 29 Jun 2026, 23:59 UTC
AI-generated source summary
The analysis focuses on the S&P 500 E-mini futures (ES1!), Bitcoin (BTCUSD), and the iShares Biotechnology ETF (IBB). ES1! is in a short-term bullish trend, having bounced from the 50% EMA and is expected to continue upwards. The failure bound for this bullish outlook is below the recent low of 7375.75. Bitcoin (BTCUSD) is in a bearish trend, having fallen below its mid-band and shows increasing bearish momentum. A confirmed breakdown below 59,000 would signal further downside, with a failure bound set at 61,740. The iShares Biotechnology ETF (IBB) is in a strong bullish uptrend, testing multi-year highs and showing strong momentum. A potential pullback to around 155.00 would be a buying opportunity, with the target around 180.00. The failure bound for this bullish outlook is set below 155.00. The overall market sentiment, particularly for Bitcoin, appears to be cautious due to bearish indicators, while the S&P 500 and IBB show continued bullish strength.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
3 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Krown
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.